Search Results

Real life evaluation of safinamide effectiveness in Parkinson's disease.

• Authors : Mancini, Francesca; Di Fonzo, Alessio; Lazzeri, Giulia

Subjects: PARKINSON'S disease treatment; TREATMENT effectiveness; FOLLOW-up studies (Medicine)

• Source: Neurological Sciences. Apr2018, Vol. 39 Issue 4, p733-739. 7p. 3 Charts.

Record details

Health-related quality of life in Parkinson's: impact of 'off' time and stated treatment preferences.

• Authors : Kerr, Cicely; Lloyd, Emily; Kosmas, Charlotte

Subjects: PARKINSON'S disease treatment; DOPA; QUALITY of lifeFRANCE; ITALY; SPAIN

• Source: Quality of Life Research. Jun2016, Vol. 25 Issue 6, p1505-1515. 11p.

Record details

Prescribing pattern and resource utilization of monoamine oxidase-B inhibitors in Parkinson treatment: comparison between rasagiline and selegiline.

• Authors : Degli Esposti, Luca; Piccinni, Carlo; Sangiorgi, Diego

Subjects: MONOAMINE oxidase inhibitors; PARKINSON'S disease treatment; SELEGILINE

• Source: Neurological Sciences. Feb2016, Vol. 37 Issue 2, p227-234. 8p. 1 Diagram, 3 Charts, 3 Graphs.

Record details

Baseline [123 I] FP- CIT SPECT (Da TSCAN) severity correlates with medication use at 3 years in Parkinson's disease.

• Authors : Nissen, T.; Malek, N.; Grosset, K. A.

Subjects: PARKINSON'S disease treatment; DOPAMINERGIC neurons; DOPAMINE receptors

• Source: Acta Neurologica Scandinavica. Mar2014, Vol. 129 Issue 3, p204-208. 5p.

Record details

Effectiveness of deep brain stimulation in Parkinson's disease treatment with Single-center experience in Pakistan Aurangzeb

• Authors : Aurangzeb Kalhoro and Abdul Sattar M. Hashim

• Source: Pakistan Journal of Medical Sciences. August 31, 2023, Vol. 39 Issue 4, p1018

Record details

Adherence to anti-Parkinson drug therapy in the “REASON” sample of Italian patients with Parkinson’s disease: the linguistic validation of the Italian version of the “Morisky Medical Adherence scale-8 items”.

• Authors : Fabbrini, G.; Abbruzzese, G.; Barone, P.

Subjects: PARKINSON'S disease treatment; ANTIPARKINSONIAN agents; PATIENT compliance

• Source: Neurological Sciences. Nov2013, Vol. 34 Issue 11, p2015-2022. 8p.

Record details

Diagnosis and Treatment of Parkinson Disease: A Review.

• Authors : Armstrong, Melissa J.; Okun, Michael S.

Subjects: PARKINSON'S disease diagnosis; PARKINSON'S disease treatment; BRAIN diseases

• Source: JAMA: Journal of the American Medical Association. 2/11/2020, Vol. 323 Issue 6, p548-560. 13p.

Record details

European Biotechs Unlocking Parkinson's Disease.

• Authors : Barton, Cheryl¹

Subjects: *BIOTECHNOLOGY; *DIFFUSION of innovations; *PROFESSIONAL associationsEUROPE

• Source: Pharmaceutical Technology Europe. Nov/Dec2024, Vol. 36 Issue 10, p16-18. 3p.

Record details

Activating Autophagy as a Therapeutic Strategy for Parkinson's Disease.

• Authors : Fowler, Alan J.; Moussa, Charbel E.-H.

Subjects: PARKINSON'S disease treatment; LEWY body dementia; SYNUCLEINS

• Source: CNS Drugs. Jan2018, Vol. 32 Issue 1, p1-11. 11p.

Record details

Safinamide: A Review in Parkinson's Disease.

• Authors : Blair, Hannah; Dhillon, Sohita; Blair, Hannah A (AUTHOR)

Subjects: PARKINSON'S disease treatment; MONOAMINE oxidase inhibitors; EXCITATORY amino acid agents

• Source: CNS Drugs. Feb2017, Vol. 31 Issue 2, p169-176. 8p.

Record details